Key result
The DD genotype of the ACE gene was associated with a 2.5-fold increased risk of diabetic retinopathy compared to the DI genotype (OR 2.48) in Iranian patients with type 2 diabetes.
Why the study?
Studies have shown ACE gene polymorphisms correlate with diabetic retinopathy progression, making elucidation of the association between ACE gene polymorphism and the risk of retinopathy crucial.
Does the ACE gene DD genotype increase susceptibility to diabetic retinopathy in patients with type 2 diabetes mellitus?
Case-Control (n=195)
No
Does the ACE gene DD genotype increase susceptibility to diabetic retinopathy in patients with type 2 diabetes mellitus?
Odds Ratio: 2.48 (95% CI 1.271–4.84)
Absolute Event Rate: 39.4% vs 19.8%
p-value: p=0.007
The DD genotype and D allele of the ACE gene are significantly associated with an increased risk of diabetic retinopathy in patients with type 2 diabetes mellitus.
No immediate change to retinopathy screening; leaves open ACE DD genotype utility pending replication in diverse cohorts.
Background: One of the major microvascular complications of diabetes mellitus (DM) is diabetic retinopathy (DR). Studies have shown that angiotensin-converting enzyme (ACE) gene polymorphisms are correlated with DR progression. Accordingly, the elucidation of the association between ACE gene polymorphism and the risk of DR development seems to be highly crucial. Methods: In this study, 195 individuals with type 2 diabetes mellitus (T2DM) were classified as the case group with retinopathy (99 people) and control group without retinopathy (96 people). Screening for DR was performed by ophthalmologists using clinical examination and fluorescein angiography. Different ACE genotypes (II, ID, and DD) were identified by the collection of blood samples, extraction of DNA, and PCR amplification using specific primers. Results: The frequency distribution of genotypes was significantly different between the case and control groups (P = 0.009). Interestingly, possessing a DD genotype made diabetic patients approximately 2.5 folds (95% CI = 1.271 - 4.840, P = 0.007) and 3.25 folds (95% CI = 1.312 - 8.051, P = 0.01) more susceptible to DR when compared to having DI and II genotypes, respectively. Moreover, having a D allele made diabetic individuals nearly 1.75 folds (95% CI = 1.167 - 2.623, P = 0.007) more susceptible to DR than possessing an I allele. Conclusions: Our results potentiate the hypothesis that the DD genotype and D allele of the ACE gene might play a role in the pathogenesis of DR.
No takes yet. Share an insight, caveat, or question.
Ali-Bahar et al. (2021) conducted a case-control in Diabetic Retinopathy in Type 2 Diabetes Mellitus (n=195). ACE gene DD genotype vs. DI and II genotypes was evaluated on Susceptibility to diabetic retinopathy (OR 2.480, 95% CI 1.271 - 4.840, p=0.007). The DD genotype of the ACE gene was associated with a 2.5-fold increased risk of diabetic retinopathy compared to the DI genotype (OR 2.48) in Iranian patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: